Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models

Our results strongly support precision therapies for MPNSTs guided by TSG inactivation status. MEKi-BETi CDKi triple treatment elicits a significant reduction of human MPNST PDOXs.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2024-12-30
DOI
https://doi.org/10.1158/1078-0432.ccr-24-2807
Citations
10
Primary Topic
Neurofibromatosis and Schwannoma Cases
Type
article
Field-Weighted Citation Impact
3.69

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models

Edgar Creus‐Bachiller, Marc Ferrer, Alberto Villanueva, Thomas De Raedt et al.
10 citations
Clinical Cancer Research
Neurofibromatosis and Schwannoma Cases
3.69
article

Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models

Edgar Creus‐Bachiller, Marc Ferrer, Alberto Villanueva, Thomas De Raedt, Claudia Valverde, Eduard Serra, Helena Mazuelas, Miriam Magallón‐Lorenz, Xiaohu Zhang, Cleofé Romagosa, Bernat Gel, Juana Fernández‐Rodríguez, Sara Ortega‐Bertran, Conxi Lázaro, Meritxell Carrió, Ignacio Blanco, Itziar Uriarte-Arrazola, Adriana Paola Diazgranados, Héctor Salvador
article en
10 citations

Abstract

Our results strongly support precision therapies for MPNSTs guided by TSG inactivation status. MEKi-BETi CDKi triple treatment elicits a significant reduction of human MPNST PDOXs.

Clinical Cancer ResearchVol. 31(5)
Hebron University (PS), National Institutes of Health (US), Hospital Sant Joan de Déu Barcelona (ES), Children's Hospital of Philadelphia (US), Bellvitge University Hospital (ES), Institut d'Investigació Biomédica de Bellvitge (ES), Departament de Salut (ES), Vall d'Hebron Institut de Recerca (ES), Ajuntament de L’Hospitalet (ES), Institut Català d'Oncologia (ES), Institute for Research in Biomedicine (ES), Vall d'Hebron Hospital Universitari (ES), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES), National Center for Advancing Translational Sciences (US), Hospital Universitari Germans Trias i Pujol (ES), Centro de Investigación Biomédica en Red de Cáncer (ES), Universitat de Barcelona (ES), University of Pennsylvania (US)
Fundació la Marató de TV3, Ministerio de Ciencia, Innovación y Universidades, Centres de Recerca de Catalunya, European Commission, Generalitat de Catalunya, Centro de Investigación Biomédica en Red de Cáncer, Agència de Gestió d'Ajuts Universitaris i de Recerca, Agencia Estatal de Investigación
Good health and well-being
Openalex Percentile: Top 6%
Neurofibromatosis and Schwannoma Cases
3.69
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.